Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -0.61% is 100% above its 5-year average of -142.63%, near the high end of its 5-year range (-1615.60%–0.00%).
99.43% above its 12-month average of -107.75%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): -0.25%.
NET PROFIT MARGIN
-0.61%
NET PROFIT MARGIN AVG TTM
-107.75%
NET PROFIT MARGIN AVG 3Y
-155.10%
NET PROFIT MARGIN AVG 5Y
-142.63%
NET PROFIT MARGIN AVG 10Y
-54.93%
NET PROFIT MARGIN AVG 15Y
-35.95%
NET PROFIT MARGIN AVG 20Y
-45.64%
CURRENT VS TTM AVG
+99.43%
CURRENT VS 3Y AVG
+99.61%
CURRENT VS 5Y AVG
+99.57%
CURRENT VS 10Y AVG
+98.89%
CURRENT VS 15Y AVG
+98.30%
CURRENT VS 20Y AVG
+98.66%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 564 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
InMed Pharmaceuticals Inc.
Market Cap
$7.31M
Net Profit Margin
-0.61%
TTM Avg
-107.75%
3Y Avg
-155.10%
5Y Avg
-142.63%
Market Cap
$7.36M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-287.91%
5Y Avg
-676.70%
Market Cap
$7.46M
Net Profit Margin
-1977.59%
TTM Avg
-1280.67%
3Y Avg
-1780.71%
5Y Avg
-1415.68%
Market Cap
$7.22M
Net Profit Margin
-4791.48%
TTM Avg
-2970.23%
3Y Avg
-7387.99%
5Y Avg
-5910.39%
Market Cap
$7.06M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-19.45%
5Y Avg
-19.45%
Market Cap
$6.88M
Net Profit Margin
-6523.04%
TTM Avg
-4247.49%
3Y Avg
-2263.82%
5Y Avg
-1493.48%
Market Cap
$7.78M
Net Profit Margin
N/A
TTM Avg
-206582.99%
3Y Avg
-143015.53%
5Y Avg
-102538.66%
Market Cap
$6.82M
Net Profit Margin
-611.47%
TTM Avg
-627.26%
3Y Avg
-917.71%
5Y Avg
-6297.45%
Market Cap
$6.80M
Net Profit Margin
-10978.48%
TTM Avg
-12422.83%
3Y Avg
-10763.38%
5Y Avg
-10131.90%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $7.31M | -0.61% | -107.75% | -155.10% | -142.63% |
| KALA BIO, Inc. (KALA)vs › | $7.36M | 0.00% | 0.00% | -287.91% | -676.70% |
| Longeveron Inc. (LGVN)vs › | $7.46M | -1977.59% | -1280.67% | -1780.71% | -1415.68% |
| Mangoceuticals, Inc. (MGRX)vs › | $7.22M | -4791.48% | -2970.23% | -7387.99% | -5910.39% |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.06M | 0.00% | 0.00% | -19.45% | -19.45% |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | -6523.04% | -4247.49% | -2263.82% | -1493.48% |
| HeartSciences Inc. (HSCS)vs › | $7.78M | N/A | -206582.99% | -143015.53% | -102538.66% |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.82M | -611.47% | -627.26% | -917.71% | -6297.45% |
| Aclarion, Inc. (ACON)vs › | $6.80M | -10978.48% | -12422.83% | -10763.38% | -10131.90% |
| GT Biopharma, Inc. (GTBP)vs › | $7.84M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-0.5%
Net Profit Margin
-0.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -0.25% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | -247.29% |
| 2025-09-30 | -154.17% |
| 2025-06-30 | -137.07% |
| 2025-03-31 | -168.12% |
| 2024-12-31 | -231.63% |
| 2024-09-30 | -132.68% |
| 2024-06-30 | -151.02% |
| 2024-03-31 | -146.93% |
| 2023-12-31 | -119.19% |
| 2023-09-30 | -281.29% |
| 2023-06-30 | -14.64% |
| 2023-03-31 | -193.24% |
| 2022-12-31 | -447.25% |
| 2022-09-30 | -1094.24% |
| 2022-06-30 | -1528.88% |
| 2022-03-31 | -1122.69% |
| 2021-12-31 | -1615.60% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | -1041.10% |
| 2011-03-31 | -1056.45% |
| 2010-12-31 | -431.02% |
| 2010-09-30 | -593.79% |
| 2010-06-30 | -133.97% |
| 2010-03-31 | -1477.99% |
| 2009-12-31 | -2981.96% |
| 2009-09-30 | -446.96% |
| 2009-06-30 | 308.32% |
| 2009-03-31 | -1047.15% |
| 2008-12-31 | -788.62% |
| 2008-09-30 | -829.03% |
| 2008-06-30 | 38.67% |
| 2008-03-31 | -75.55% |
| 2007-12-31 | -83.86% |
| 2007-09-30 | -248.35% |
| 2007-06-30 | -156.93% |
| 2007-03-31 | -52.27% |
| 2006-12-31 | -172.35% |
| 2006-09-30 | -71.96% |
| 2006-06-30 | -32.72% |
| 2006-03-31 | -76.19% |
| 2005-12-31 | -30.54% |
| 2005-09-30 | -48.48% |
| 2005-06-30 | -108.77% |
| 2005-03-31 | -24.75% |
| 2004-12-31 | -31.38% |
| 2004-09-30 | -148.59% |
| 2004-07-31 | -158.31% |
| 2004-04-30 | -49.05% |
| 2004-01-31 | -64.31% |
| 2003-10-31 | -39.86% |
| 2003-07-31 | -256.28% |
| 2003-04-30 | -1378.89% |
| 2003-01-31 | -46858.43% |
| 2002-10-31 | -3759.80% |
